Recombinant DNA Technology
Recombinant DNA technology, relate together of DNA molecules from two various species that are inserted into a host organism to produce new genetic combinations that are of value to science, medicine, agriculture, and industry. The Processes of Recombinant gene DNA Technology is joining DNA molecules from two different interesting and sources them into a host organism, to generate products for human use. The applications of health and nutrition, in medicine it is used to create pharmaceutical products such as human insulin and In agriculture it is used to impart approving characteristics to plant to increase their yield and improve nutritional content of Recombinant DNA technology.
- Production of clotting factors and insulin
- Creation of Recombinant DNA with DNA ligase
- Selection of organisms containing vector sequences
- Production of recombinant pharmaceuticals
- DNA-Binding Proteins
- Recombinant Virus
- Germ line and Somatic Gene Therapy
Related Conference of Recombinant DNA Technology
November 16-17, 2026
19th International Conference on Human Genomics and Genomic Medicine
Tokyo, Japan
February 18-19, 2027
22nd World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
March 11-12, 2027
17th International Conference on Human Genetics and Genetic Diseases
Berlin, Germany
Recombinant DNA Technology Conference Speakers
Recommended Sessions
- Animal cells & Microbial Interactions
- Calcium and Cell Function
- Cancer Genomics
- Cell and Immunology
- Cell Cycle and Cytogenetics
- Cell Physiology and Biochemistry
- Cellular Metabolism & Signalling
- Clinical & Pharmacogenomics
- Computational Biology & Next generation sequencing
- Data integration, Modelling and prediction
- Epigenetics & Metagenomics
- Gene expression & Genetic Changes
- Genomic Medicine
- Human Genomics
- Membrane Processes
- Microbial Glycobiology & Genomics
- Molecular Biology & Transcriptomics
- Molecular Biology Techniques
- Molecular Cell Biology
- Plant Biology & Genomics
- Population & Evolutionary Genomics
- Proteomics and Transcriptomics
- Recombinant DNA Technology
- Single Cell biology
- Stem Cells & Tissue Engineering
- Structural & Functional Genomics
- Structural Biology
- Yeast artificial Chromosome
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2026 (UAE)
- Advanced Imaging and Single-Cell Technologies - cellscience-cs-2027 (UK)
- Animal Genetics - Genome 2027 (Germany)
- Artificial Intelligence in Cell and Molecular Research - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - cellscience-cs-2027 (UK)
- Bioinformatics and Computational Biology - Genome 2027 (Germany)
- Biomarkers and Microarrays - Genome 2027 (Germany)
- Biotechnology and Molecular Therapeutics - cellscience-cs-2027 (UK)
- Cancer and stem cells - CRISPR 2026 (UAE)
- Cancer Cell Biology and Molecular Oncology - cellscience-cs-2027 (UK)
- Cancer Genomics - Genome 2027 (Germany)
- Cell Biology and Cellular Mechanisms - cellscience-cs-2027 (UK)
- Cellular Metabolism and Metabolic Biology - cellscience-cs-2027 (UK)
- Cellular signaling and Signal Transduction - cellscience-cs-2027 (UK)
- Clinical genomics - Genome 2027 (Germany)
- Comparative Genomics - Genome 2027 (Germany)
- CRISPR technologies and society - CRISPR 2026 (UAE)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2026 (UAE)
- Emerging Technologies and Future Directions in Cell Science - cellscience-cs-2027 (UK)
- Epigenomics and Epigenetics - Genome 2027 (Germany)
- Functional Genomics - Genome 2027 (Germany)
- Gene Editing and Genetic Engineering - Genome 2027 (Germany)
- Genetic Disorder - Genome 2027 (Germany)
- Genetics, Genomics and Genome Biology - cellscience-cs-2027 (UK)
- Genome editing and gene regulation in human health - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2026 (UAE)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2026 (UAE)
- Genome Editing Methods and Novel Tools - CRISPR 2026 (UAE)
- Genomic Instability - Genome 2027 (Germany)
- Genomic Medicine - Genome 2027 (Germany)
- Horizons of CRISPR biology - CRISPR 2026 (UAE)
- Immunology and Cellular Immunity - cellscience-cs-2027 (UK)
- Microbial Genomics - Genome 2027 (Germany)
- Molecular Biology and Gene Regulation - cellscience-cs-2027 (UK)
- Molecular Diagnostics and Biomarkers - cellscience-cs-2027 (UK)
- Molecular Medicine and Translational Research - cellscience-cs-2027 (UK)
- Molecular Microbiology and Host–Pathogen Interactions - cellscience-cs-2027 (UK)
- Next generation sequencing - Genome 2027 (Germany)
- Nutrigenomics - Genome 2027 (Germany)
- Personalized and Regenerative Medicine - Genome 2027 (Germany)
- Pharmacogenomics - Genome 2027 (Germany)
- Plant and Animal Biotechnology - CRISPR 2026 (UAE)
- Plant Genomics and Molecular Pharming - Genome 2027 (Germany)
- Stem Cell Biology and Regenerative Medicine - cellscience-cs-2027 (UK)
- Structural Biology and Bioinformatics - CRISPR 2026 (UAE)
- Structural Genomics - Genome 2027 (Germany)
- Therapeutic Genome Editing - CRISPR 2026 (UAE)
- Trends in Genomics and Pharmacogenomics - Genome 2027 (Germany)